Annual report pursuant to Section 13 and 15(d)

Loss Per Share (Details) - Schedule of Common Stock Equivalents

v3.24.3
Loss Per Share (Details) - Schedule of Common Stock Equivalents - shares
 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 43,195,179 12,497,862
Convertible Notes [Member]    
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 9,341,825 9,341,825
Options [Member]    
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 2,853,354 3,156,037
Warrants [Member]    
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 31,000,000